Your session is about to expire
← Back to Search
Digital Health Interventions for COVID-19
Study Summary
This trial will increase access to COVID-19 testing and vaccination among underserved populations in Utah using PHM interventions and available technology.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I speak English or Spanish.I am under 18 years old.
- Group 1: Conversational Agent (CA)+ No Patient Navigation
- Group 2: Conversational Agent (CA) + Request PN (RPN)
- Group 3: Text Messaging (TM) + No Patient Navigation
- Group 4: Text Message (TM) + Request (RPN)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any remaining spots available for the trial?
"This clinical trial is currently seeking participants, with records of its posting and last update dates being available on clinicaltrials.gov. The study was originally posted to the site on 15th January 2023 and the most recent updates occurred 8th May 2023."
Could you provide an estimation of the number of participants who have agreed to join this experiment?
"Affirmative, data posted to clinicaltrials.gov indicates that the trial is actively seeking participants and was initially posted on 15 January 2023 with a subsequent update dated 8 May 2023. The study necessitates 112479 individuals at one site for enrollment."
Share this study with friends
Copy Link
Messenger